NYSE - Delayed Quote USD

Bio-Rad Laboratories, Inc. (BIO)

275.94 +0.34 (+0.12%)
At close: April 26 at 4:00 PM EDT
276.89 +0.95 (+0.34%)
After hours: April 26 at 5:59 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Norman D. Schwartz Chairman, CEO & President 1.25M 19.51M 1950
Dr. Andrew J. Last Ph.D. Executive VP & COO 682.29k -- 1960
Dr. Simon May Executive VP & President of the Life Science Group 536.25k -- 1972
Mr. Roop K. Lakkaraju Executive VP & CFO -- -- 1971
Ms. Tania DeVilliers Senior Director, Corporate Controller & Interim Principal Accounting Officer -- -- 1974
Mr. Yong Chung Vice President of Investor Relations -- -- --
Mr. Timothy S. Ernst Executive VP, General Counsel & Secretary -- -- 1960
Matthew Werner Senior Vice President and Chief Compliance & Privacy Officer -- -- --
Ms. Colleen Corey Executive Vice President of Global Human Resources -- -- 1962
Mr. Michael Crowley Executive Vice President of Global Commercial Operations 974.94k 1.85M 1962

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000 https://www.bio-rad.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
8,030

Description

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Corporate Governance

Bio-Rad Laboratories, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 10; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 07, 2024
Bio-Rad Laboratories, Inc. Earnings Call

Related Tickers

PODD Insulet Corporation
166.19
+1.23%
 
MASI Masimo Corporation
136.14
+0.67%
 
PEN Penumbra, Inc.
204.41
-0.53%
 
ZBH Zimmer Biomet Holdings, Inc.
119.35
-0.33%
 
EW Edwards Lifesciences Corporation
86.43
-1.80%
 
QDEL QuidelOrtho Corporation
39.64
-0.13%
 
ITGR Integer Holdings Corporation
109.58
-1.41%
 
BRKR Bruker Corporation
80.97
+0.47%
 
IART Integra LifeSciences Holdings Corporation
28.34
-0.25%
 
STE STERIS plc
203.90
+1.17%